St. Vincent’s Riverside is now offering a breakthrough treatment for patients diagnosed with chronic pulmonary obstructive ...

Censoring research on how to deliver treatments to those most in need isn’t just nonsensical; it puts lives at risk and ...

People in rural areas are at greater risk of developing chronic obstructive pulmonary disease (COPD) due to a variety of factors. We explain why.

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...

People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...

Despite successful models in a few parts of India where regulated access to opioids has been implemented safely, there ...

”We are excited to welcome Dr. Aaron Waxman to our Board of Directors,” said David Scheer, Chairman of the Board of Directors at OrphAI. "His clinical leadership will be an important contribution to ...

The median length of survival for individuals with ILD who completed pulmonary rehabilitation was 6.1 years vs 4.7 years in the control group. Pulmonary rehabilitation (PR) may improve survival at 5 ...

There are certain risk factors for COPD, including obesity and having type ... internist and critical care specialist at MemorialCare Long Beach Medical Center in Long Beach, CA, about this ...

Over the last decade, as the Institute for Clinical and Economic Review (ICER) has estimated the cost-effectiveness of newly ...

Pope Francs has been diagnosed with pneumonia in both lungs. He is receiving antibiotics, steroids and oxygen therapy. While ...